Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Alzheimer's Disease

  Free Subscription


Articles published in Neurosci Lett

Retrieve available abstracts of 88 articles:
HTML format
Text format



Single Articles


    May 2018
  1. RASHID H, Ahmed T
    Gender Dependent Contribution of Muscarinic Receptors in Memory Retrieval under Sub-Chronic Stress.
    Neurosci Lett. 2018 May 15. pii: S0304-3940(18)30359.
    PubMed     Text format     Abstract available


  2. CHUNG KM, Hernandez N, Sproul A, Yu WH, et al
    Alzheimer's disease and the autophagic-lysosomal system.
    Neurosci Lett. 2018 May 11. pii: S0304-3940(18)30344.
    PubMed     Text format     Abstract available


    April 2018
  3. FANG L, Tang BS, Fan K, Wan CM, et al
    Alzheimer's disease susceptibility genes modify the risk of Parkinson disease and Parkinson's disease-associated cognitive impairment.
    Neurosci Lett. 2018 Apr 23. pii: S0304-3940(18)30305.
    PubMed     Text format     Abstract available


  4. KUMAR A, Singh S, Verma A, Mishra VN, et al
    Proteomics based identification of differential plasma proteins and changes in white matter integrity as markers in early detection of mild cognitive impaired subjects at high risk of Alzheimer's disease.
    Neurosci Lett. 2018 Apr 9. pii: S0304-3940(18)30276.
    PubMed     Text format     Abstract available


  5. WU M, Zhou F, Cao X, Yang J, et al
    Abnormal circadian locomotor rhythms and Per gene expression in six-month-old triple transgenic mice model of Alzheimer's disease.
    Neurosci Lett. 2018;676:13-18.
    PubMed     Text format     Abstract available


    March 2018
  6. MAPLE-GRODEM J, Chung J, Lunde KA, Tzoulis C, et al
    Alzheimer disease associated variants in SORL1 accelerate dementia development in Parkinson disease.
    Neurosci Lett. 2018;674:123-126.
    PubMed     Text format     Abstract available


    February 2018
  7. JENSEN HLB, Lillenes MS, Rabano A, Gunther CC, et al
    Expression of nucleotide excision repair in Alzheimer's disease is higher in brain tissue than in blood.
    Neurosci Lett. 2018;672:53-58.
    PubMed     Text format     Abstract available


    January 2018
  8. NAGATA K, Mano T, Murayama S, Saido TC, et al
    DNA methylation level of the neprilysin promoter in Alzheimer's disease brains.
    Neurosci Lett. 2018 Jan 12. pii: S0304-3940(18)30003.
    PubMed     Text format     Abstract available


    December 2017
  9. ZHANG J, Guo Y, Wang Y, Song L, et al
    Long-term treadmill exercise attenuates Abeta burdens and astrocyte activation in APP/PS1 mouse model of Alzheimer's disease.
    Neurosci Lett. 2017;666:70-77.
    PubMed     Text format     Abstract available


  10. DA ROCHA TJ, Silva Alves M, Guisso CC, de Andrade FM, et al
    Association of GPX1 and GPX4 polymorphisms with episodic memory and Alzheimer's disease.
    Neurosci Lett. 2017;666:32-37.
    PubMed     Text format     Abstract available


    November 2017
  11. FEHER A, Giricz Z, Juhasz A, Pakaski M, et al
    ABCA1 rs2230805 and rs2230806 common gene variants are associated with Alzheimer's disease.
    Neurosci Lett. 2017;664:79-83.
    PubMed     Text format     Abstract available


    September 2017
  12. WANG L, Xu XB, You WW, Lin XX, et al
    The cytoplasmic nuclear shuttling of Beclin 1 in neurons with Alzheimer's disease-like injury.
    Neurosci Lett. 2017;661:63-70.
    PubMed     Text format     Abstract available


  13. MA X, Liu L, Meng J
    MicroRNA-125b promotes neurons cell apoptosis and Tau phosphorylation in Alzheimer's disease.
    Neurosci Lett. 2017 Sep 22. pii: S0304-3940(17)30785.
    PubMed     Text format     Abstract available


  14. BRUNNER D, Flunkert S, Neddens J, Duller S, et al
    SEN1500, a novel oral amyloid-beta aggregation inhibitor, attenuates brain pathology in a mouse model of Alzheimer's disease.
    Neurosci Lett. 2017 Sep 13. pii: S0304-3940(17)30770.
    PubMed     Text format     Abstract available


  15. GIAUME C, Saez JC, Song W, Leybaert L, et al
    Connexins and Pannexins in Alzheimer's Disease.
    Neurosci Lett. 2017 Sep 8. pii: S0304-3940(17)30740.
    PubMed     Text format     Abstract available


    August 2017
  16. LING J, Huang Y, Zhang L, Wei D, et al
    Association of KIBRA polymorphism with risk of Alzheimer's Disease: Evidence based on 20 case-control studies.
    Neurosci Lett. 2017 Aug 28. pii: S0304-3940(17)30717.
    PubMed     Text format     Abstract available


  17. WANG ML, Wei XE, Yu MM, Li PY, et al
    Self-reported traumatic brain injury and in vivo measure of AD-vulnerable cortical thickness and AD-related biomarkers in the ADNI cohort.
    Neurosci Lett. 2017;655:115-120.
    PubMed     Text format     Abstract available


  18. ZHANG H, Liu D, Wang Y, Huang H, et al
    Meta-analysis of expression and function of neprilysin in Alzheimer's disease.
    Neurosci Lett. 2017;657:69-76.
    PubMed     Text format     Abstract available


    July 2017
  19. RINGMAN JM, Casado M, Van Berlo V, Pa J, et al
    A novel PSEN1 (S230N) mutation causing early-onset Alzheimer's Disease associated with prosopagnosia, hoarding, and Parkinsonism.
    Neurosci Lett. 2017 Jul 29. pii: S0304-3940(17)30618.
    PubMed     Text format     Abstract available


  20. GARCIA-ESCUDERO V, Gargini R, Martin-Maestro P, Garcia E, et al
    Tau mRNA 3'UTR-to-CDS ratio is increased in Alzheimer disease.
    Neurosci Lett. 2017 Jul 6. pii: S0304-3940(17)30558.
    PubMed     Text format     Abstract available


    June 2017
  21. PINTANA H, Apaijai N, Kerdphoo S, Pratchayasakul W, et al
    Hyperglycemia induced the Alzheimer's proteins and promoted loss of synaptic proteins in advanced-age female Goto-Kakizaki (GK) rats.
    Neurosci Lett. 2017 Jun 23. pii: S0304-3940(17)30532.
    PubMed     Text format     Abstract available


    May 2017
  22. MINAKAWA EN, Miyazaki K, Maruo K, Yagihara H, et al
    Chronic sleep fragmentation exacerbates amyloid beta deposition in Alzheimer's disease model mice.
    Neurosci Lett. 2017 May 26. pii: S0304-3940(17)30452.
    PubMed     Text format     Abstract available


  23. ABDALA BB, Dos Antos JM, Goncalves AP, da Motta LB, et al
    INFLUENCE OF LOW FREQUENCY PSEN1 VARIANTS ON FAMILIAL ALZHEIMER'S DISEASE RISK IN BRAZIL.
    Neurosci Lett. 2017 May 26. pii: S0304-3940(17)30451.
    PubMed     Text format     Abstract available


  24. WU M, He Y, Zhang J, Yang J, et al
    Co-injection of Abeta1-40 and ApoE4 impaired spatial memory and hippocampal long-term potentiation in rats.
    Neurosci Lett. 2017;648:47-52.
    PubMed     Text format     Abstract available


  25. SINGH SK, Srivastav S, Yadav AK, Srikrishna S, et al
    Knockdown of APPL mimics transgenic Abeta induced neurodegenerative phenotypes in Drosophila.
    Neurosci Lett. 2017;648:8-13.
    PubMed     Text format     Abstract available


    April 2017
  26. CHEN L, Huang J, Yang L, Zeng XA, et al
    Sleep deprivation accelerates the progression of alzheimer's disease by influencing Abeta-related metabolism.
    Neurosci Lett. 2017;650:146-152.
    PubMed     Text format     Abstract available


  27. ZHOU W, Zhang J, Ye F, Xu G, et al
    Plasma neurofilament light chain levels in Alzheimer's disease.
    Neurosci Lett. 2017 Apr 17. pii: S0304-3940(17)30328.
    PubMed     Text format     Abstract available


  28. GRAY NE, Zweig JA, Murchison C, Caruso M, et al
    Centella asiatica attenuates Abeta-induced neurodegenerative spine loss and dendritic simplification.
    Neurosci Lett. 2017;646:24-29.
    PubMed     Text format     Abstract available


  29. KUNKLE BW, Carney RM, Kohli MA, Naj AC, et al
    Targeted sequencing of ABCA7 identifies splicing, stop-gain and intronic risk variants for Alzheimer disease.
    Neurosci Lett. 2017 Apr 8. pii: S0304-3940(17)30305.
    PubMed     Text format     Abstract available


  30. LILLENES MS, Stoen M, Gunther CC, Selnes P, et al
    Mitochondrial transcription factor A (TFAM) rs1937 and AP endonuclease 1 (APE1) rs1130409 alleles are associated with reduced cognitive performance.
    Neurosci Lett. 2017;645:46-52.
    PubMed     Text format     Abstract available


    March 2017
  31. JIANG S, Yan C, Qiao Z, Yao H, et al
    Mismatch negativity as a potential neurobiological marker of early-stage Alzheimer disease and vascular dementia.
    Neurosci Lett. 2017;647:26-31.
    PubMed     Text format     Abstract available


  32. YAO Z, Yang W, Gao Z, Jia P, et al
    Nicotinamide mononucleotide inhibits JNK activation to reverse Alzheimer disease.
    Neurosci Lett. 2017 Mar 18. pii: S0304-3940(17)30246.
    PubMed     Text format     Abstract available


  33. NGUYEN KV, Nyhan WL
    Quantification of various APP-mRNA isoforms and epistasis in Lesch-Nyhan disease.
    Neurosci Lett. 2017;643:52-58.
    PubMed     Text format     Abstract available


  34. HAN X, Tang S, Dong L, Song L, et al
    Loss of nitrergic and cholinergic neurons in the enteric nervous system of APP/PS1 transgenic mouse model.
    Neurosci Lett. 2017;642:59-65.
    PubMed     Text format     Abstract available


  35. DE OLIVEIRA FF, Chen ES, Smith MC, Bertolucci PH, et al
    Longitudinal lipid profile variations and clinical change in Alzheimer's disease dementia.
    Neurosci Lett. 2017 Mar 5. pii: S0304-3940(17)30205.
    PubMed     Text format     Abstract available


    February 2017
  36. MIKI Y, Tanji K, Mori F, Kakita A, et al
    PLA2G6 accumulates in Lewy bodies in PARK14 and idiopathic Parkinson's disease.
    Neurosci Lett. 2017 Feb 14. pii: S0304-3940(17)30133.
    PubMed     Text format     Abstract available


  37. LI L, Zi X, Hou D, Tu Q, et al
    Kruppel-like factor 4 regulates Amyloid-beta (Abeta)-induced neuroinflammation in Alzheimer's disease.
    Neurosci Lett. 2017 Feb 8. pii: S0304-3940(17)30123.
    PubMed     Text format     Abstract available


  38. WU Y, Ma Y, Liu Z, Geng Q, et al
    Alterations of myelin morphology and oligodendrocyte development in early stage of Alzheimer's disease mouse model.
    Neurosci Lett. 2017 Feb 5. pii: S0304-3940(17)30113.
    PubMed     Text format     Abstract available


  39. CHEN L, Ou S, Zhou L, Tang H, et al
    Formononetin attenuates Abeta25-35-induced cytotoxicity in HT22 cells via PI3K/Akt signaling and non-amyloidogenic cleavage of APP.
    Neurosci Lett. 2017;639:36-42.
    PubMed     Text format     Abstract available


    January 2017
  40. MURATA-SHINOZAKI Y, Takahashi T, Matsubara T, Maruyama H, et al
    The origins of rimmed vacuoles and granulovacuolar degeneration bodies are associated with the Wnt signaling pathway.
    Neurosci Lett. 2017;638:55-59.
    PubMed     Text format     Abstract available


  41. BRIFFA M, Ghio S, Neuner J, Gauci AJ, et al
    Extracts from two ubiquitous Mediterranean plants ameliorate cellular and animal models of neurodegenerative proteinopathies.
    Neurosci Lett. 2017;638:12-20.
    PubMed     Text format     Abstract available


  42. GABRIEL AJ, Almeida MR, Ribeiro MH, Duraes J, et al
    Association between butyrylcholinesterase and cerebrospinal fluid biomarkers in Alzheimer's disease patients.
    Neurosci Lett. 2017 Jan 17. pii: S0304-3940(17)30046.
    PubMed     Text format     Abstract available


  43. ZIS P, Strydom A, Buckley D, Adekitan D, et al
    Cognitive ability in Down syndrome and its relationship to urinary neopterin, a marker of activated cellular immunity.
    Neurosci Lett. 2017;636:254-257.
    PubMed     Text format     Abstract available


  44. LIU G, Ji H, Liu J, Xu C, et al
    Association of OPRK1 and OPRM1 methylation with mild cognitive impairment in Xinjiang Han and Uygur populations.
    Neurosci Lett. 2017;636:170-176.
    PubMed     Text format     Abstract available


  45. CHAI GS, Wang YY, Zhu D, Yasheng A, et al
    Activation of beta2-adrenergic receptor promotes dendrite ramification and spine generation in APP/PS1 mice.
    Neurosci Lett. 2017;636:158-164.
    PubMed     Text format     Abstract available


  46. MCINTOSH EC, Jacobson A, Kemmotsu N, Pongpipat E, et al
    Does medial temporal lobe thickness mediate the association between risk factor burden and memory performance in middle-aged or older adults with metabolic syndrome?
    Neurosci Lett. 2017;636:225-232.
    PubMed     Text format     Abstract available


    December 2016
  47. ARMIJO E, Gonzalez C, Shahnawaz M, Flores A, et al
    Increased susceptibility to Abeta toxicity in neuronal cultures derived from familial Alzheimer's disease (PSEN1-A246E) induced pluripotent stem cells.
    Neurosci Lett. 2016;639:74-81.
    PubMed     Text format     Abstract available


    July 2016
  48. KANG WS, Park JK, Kim YJ, Cho AR, et al
    Association of tripartite motif family-like 2 (TRIML2) polymorphisms with late-onset Alzheimer's disease risk in a Korean population.
    Neurosci Lett. 2016 Jul 25. pii: S0304-3940(16)30540.
    PubMed     Text format     Abstract available


  49. DENG Y, Shi L, Lei Y, Wang D, et al
    Altered Topological Organization of High-Level Visual Networks in Alzheimer's Disease and Mild Cognitive Impairment Patients.
    Neurosci Lett. 2016 Jul 23. pii: S0304-3940(16)30537.
    PubMed     Text format     Abstract available


  50. VELDMAN ER, Jia Z, Halldin C, Svedberg MM, et al
    Amyloid binding properties of curcumin analogues in Alzheimers disease postmortem brain tissue.
    Neurosci Lett. 2016 Jul 23. pii: S0304-3940(16)30539.
    PubMed     Text format     Abstract available


  51. LI Y, Xu J, Xu P, Song S, et al
    Xanthoceras sorbifolia extracts ameliorate dendritic spine deficiency and cognitive decline via upregulation of BDNF expression in a rat model of Alzheimer's disease.
    Neurosci Lett. 2016 Jul 10. pii: S0304-3940(16)30497.
    PubMed     Text format     Abstract available


  52. TREBBASTONI A, D'Antonio F, Bruscolini A, Marcelli M, et al
    Retinal nerve fibre layer thickness changes in Alzheimer's disease: Results from a 12-month prospective case series.
    Neurosci Lett. 2016 Jul 6. pii: S0304-3940(16)30492.
    PubMed     Text format     Abstract available


    June 2016
  53. SHISHIDO H, Kishimoto Y, Kawai N, Toyota Y, et al
    Traumatic brain injury accelerates amyloid-beta deposition and impairs spatial learning in the triple-transgenic mouse model of Alzheimer's disease.
    Neurosci Lett. 2016 Jun 29. pii: S0304-3940(16)30475.
    PubMed     Text format     Abstract available


  54. SHINAGAWA S, Kobayashi N, Nagata T, Kusaka A, et al
    DNA methylation in the NCAPH2/LMF2 promoter region is associated with hippocampal atrophy in Alzheimer's disease and amnesic mild cognitive impairment patients.
    Neurosci Lett. 2016 Jun 26. pii: S0304-3940(16)30464.
    PubMed     Text format     Abstract available


  55. HUANG H, Zhao J, Xu B, Ma X, et al
    The TOMM40 Gene rs2075650 Polymorphism Contributes to Alzheimer's disease in Caucasian, and Asian Populations.
    Neurosci Lett. 2016 Jun 17. pii: S0304-3940(16)30378.
    PubMed     Text format     Abstract available


    May 2016
  56. MICHELI F, Palermo R, Talora C, Ferretti E, et al
    Regulation of proapoptotic proteins Bak1 and p53 by miR-125b in an experimental model of Alzheimer's disease: protective role of 17beta-Estradiol.
    Neurosci Lett. 2016 May 25. pii: S0304-3940(16)30377.
    PubMed     Text format     Abstract available


  57. LI YQ, Tan MS, Wang HF, Tan CC, et al
    Corrigendum to "Common variant in PTK2B is associated with late-onset Alzheimer's disease: A replication study and meta-analyses" [Neurosci. Lett. 621 (2016) 83-87].
    Neurosci Lett. 2016 May 24. pii: S0304-3940(16)30325.
    PubMed     Text format    


    April 2016
  58. GUPTA VK, Chitranshi N, Gupta VB, Golzan M, et al
    Amyloid beta accumulation and Inner retinal degenerative changes in Alzheimer's disease transgenic mouse.
    Neurosci Lett. 2016 Apr 28. pii: S0304-3940(16)30281.
    PubMed     Text format     Abstract available


  59. LI YQ, Tan MS, Wang HF, Tan CC, et al
    Common variant in PTK2B is associated with late-onset Alzheimer's disease: A Replication Study and Meta-Analyses.
    Neurosci Lett. 2016 Apr 11. pii: S0304-3940(16)30225.
    PubMed     Text format     Abstract available


  60. SANDOVAL-HERNANDEZ AG, Restrepo A, Cardona-Gomez GP, Arboleda G, et al
    LXR activation protects hippocampal microvasculature in very old triple transgenic mouse model of Alzheimer's disease.
    Neurosci Lett. 2016 Apr 4. pii: S0304-3940(16)30212.
    PubMed     Text format     Abstract available


    March 2016
  61. JIA F, Liu Z, Song N, Du X, et al
    The association between CYP46A1 rs4900442 polymorphism and the risk of Alzheimer's disease: A meta-analysis.
    Neurosci Lett. 2016 Mar 26. pii: S0304-3940(16)30194.
    PubMed     Text format     Abstract available


  62. CHOI MH, Kim HS, Gim SY, Kim WR, et al
    Differences in cognitive ability and hippocampal volume between Alzheimer's disease, amnestic mild cognitive impairment, and healthy control groups, and their correlation.
    Neurosci Lett. 2016 Mar 24. pii: S0304-3940(16)30182.
    PubMed     Text format     Abstract available


  63. REN L, Ren X
    Meta-analyses of four polymorphisms of lipoprotein lipase associated with the risk of Alzheimer's disease.
    Neurosci Lett. 2016 Mar 11. pii: S0304-3940(16)30151.
    PubMed     Text format     Abstract available


  64. XIE L, Yan H, Shi L, Kong Y, et al
    Association between CYP17A1 rs3824755 and rs743572 gene polymorphisms and Alzheimer's disease in the Chinese Han population.
    Neurosci Lett. 2016;618:77-82.
    PubMed     Text format     Abstract available


  65. MUN MJ, Kim JH, Choi JY, Jang WC, et al
    Calcium homeostasis modulator 1 gene P86L polymorphism and the risk for alzheimer's disease: A meta-analysis.
    Neurosci Lett. 2016 Mar 1. pii: S0304-3940(16)30115.
    PubMed     Text format     Abstract available


    February 2016
  66. WOLTERS FJ, Koudstaal PJ, Hofman A, Duijn CM, et al
    Serum apolipoprotein E is associated with long-term risk of Alzheimer's disease: the Rotterdam Study.
    Neurosci Lett. 2016 Feb 11. pii: S0304-3940(16)30085.
    PubMed     Text format     Abstract available


    January 2016
  67. YU M, Liu Y, Shen J, Lv D, et al
    Meta-Analysis of BACE1 Gene rs638405 Polymorphism and the risk of Alzheimer's Disease in Caucasion and Asian population.
    Neurosci Lett. 2016 Jan 29. pii: S0304-3940(16)30058.
    PubMed     Text format     Abstract available


  68. YUAN L, Sun M, Chen Y, Long M, et al
    Non-Gaussian diffusion alterations on diffusion kurtosis imaging in patients with early alzheimer's disease.
    Neurosci Lett. 2016 Jan 18. pii: S0304-3940(16)30020.
    PubMed     Text format     Abstract available


  69. LU J, Fu J, Zhong Y, Chen P, et al
    The roles of apolipoprotein E3 and CYP2D6 (rs1065852) gene polymorphisms in the predictability of responses to individualized therapy with donepezil in Han Chinese patients with Alzheimer's disease.
    Neurosci Lett. 2016;614:43-48.
    PubMed     Text format     Abstract available


    December 2015
  70. RAMOS DOS SANTO L, Belcavello L, Camporez D, Iamonde Maciel de Magalhaes C, et al
    Association study of the BIN1 and IL-6 genes on Alzheimer's disease.
    Neurosci Lett. 2015 Dec 27. pii: S0304-3940(15)30337.
    PubMed     Text format     Abstract available


  71. MISIK J, Korabecny J, Nepovimova E, Kracmarova A, et al
    Effects of novel tacrine-related cholinesterase inhibitors in the reversal of 3-quinuclidinyl benzilate-induced cognitive deficit in rats - is there a potential for Alzheimer's disease treatment?
    Neurosci Lett. 2015 Dec 18. pii: S0304-3940(15)30311.
    PubMed     Text format     Abstract available


    November 2015
  72. WANG Z, Wei X, Yang J, Suo J, et al
    Chronic exposure to aluminum and risk of Alzheimer's disease: A meta-analysis.
    Neurosci Lett. 2015 Nov 16. pii: S0304-3940(15)30251.
    PubMed     Text format     Abstract available


  73. ANDREA T, Antonella B, Irene P, Sara F, et al
    Novel presenilin 1 mutation (Ile408Thr) in an Italian family with late-onset Alzheimer's disease.
    Neurosci Lett. 2015 Nov 5. pii: S0304-3940(15)30241.
    PubMed     Text format     Abstract available


  74. HASKINS M, Jones TE, Lu Q, Bareiss SK, et al
    Early alterations in blood and brain RANTES and MCP-1 expression and the effect of exercise frequency in the 3xTg-AD mouse model of Alzheimer's disease.
    Neurosci Lett. 2015 Nov 4. pii: S0304-3940(15)30239.
    PubMed     Text format     Abstract available


    October 2015
  75. LI L, Wang XY, Gao FB, Wang L, et al
    Magnetic resonance T2 relaxation time at 7 Tesla associated with amyloid beta pathology and age in a double-transgenic mouse model of Alzheimer's disease.
    Neurosci Lett. 2015 Oct 28. pii: S0304-3940(15)30222.
    PubMed     Text format     Abstract available


  76. YAMAZAKI H, Jin Y, Tsuchiya A, Kanno T, et al
    Adipose-derived stem cell-conditioned medium ameliorates antidepression-related behaviors in the mouse model of Alzheimer's disease.
    Neurosci Lett. 2015;609:53-57.
    PubMed     Text format     Abstract available


  77. MAO YF, Guo ZY, Pu JL, Zhang YC, et al
    Association of CD33 and MS4A cluster variants with Alzheimer's disease in East Asian Populations.
    Neurosci Lett. 2015 Oct 8. pii: S0304-3940(15)30170.
    PubMed     Text format     Abstract available


  78. JOHANSSON P, Almqvist EG, Wallin A, Johansson JO, et al
    Cerebrospinal fluid substance P concentrations are elevated in patients with Alzheimer's disease.
    Neurosci Lett. 2015 Oct 7. pii: S0304-3940(15)30169.
    PubMed     Text format     Abstract available


  79. CHEN W, Mao L, Xing H, Xu L, et al
    Lycopene attenuates Abeta secretion and its toxicity in human cell and Caenorhabditis elegans models of Alzheimer disease.
    Neurosci Lett. 2015 Oct 7. pii: S0304-3940(15)30172.
    PubMed     Text format     Abstract available


    August 2015
  80. JI H, Wang Y, Liu G, Xu X, et al
    OPRK1 promoter hypermethylation increases the risk of Alzheimer's disease.
    Neurosci Lett. 2015 Aug 20. pii: S0304-3940(15)30097.
    PubMed     Text format     Abstract available


  81. GU C, Shen T, An H, Yuan C, et al
    Combined therapy of Di-Huang-Yi-Zhi with Donepezil in patients with Parkinson's disease dementia.
    Neurosci Lett. 2015 Aug 18. pii: S0304-3940(15)30089.
    PubMed     Text format     Abstract available


  82. CARBONI L, Lattanzio F, Candeletti S, Porcellini E, et al
    Peripheral leukocyte expression of the potential biomarker proteins Bdnf, Sirt1, and Psen1 is not regulated by promoter methylation in Alzheimer's disease patients.
    Neurosci Lett. 2015 Aug 11. pii: S0304-3940(15)30082.
    PubMed     Text format     Abstract available


    July 2015
  83. BAETA-CORRAL R, Defrin R, Pick CG, Gimenez-Llort L, et al
    Tail-flick test response in 3xTg-AD mice at early and advanced stages of disease.
    Neurosci Lett. 2015;600:158-63.
    PubMed     Text format     Abstract available


  84. MAIRUAE N, Connor JR, Lee S, Cheepsunthorn P, et al
    The effects of okra (Abelmoschus esculentus Linn) on the cellular events associated with Alzheimer's disease in a stably expressed HFE neuroblastoma SH-SY5Y cell line.
    Neurosci Lett. 2015 Jul 10. pii: S0304-3940(15)30031.
    PubMed     Text format     Abstract available


  85. HONJO Y, Ayaki T, Tomiyama T, Horibe T, et al
    Increased GADD34 in oligodendrocytes in Alzheimer's disease.
    Neurosci Lett. 2015 Jul 1. pii: S0304-3940(15)30017.
    PubMed     Text format     Abstract available


    June 2015
  86. TANNORELLA P, Stoccoro A, Tognoni G, Petrozzi L, et al
    Methylation analysis of multiple genes in blood DNA of Alzheimer's disease and healthy individuals.
    Neurosci Lett. 2015 Jun 12. pii: S0304-3940(15)00438.
    PubMed     Text format     Abstract available


    May 2015
  87. TAJEDDINN W, Persson T, Maioli S, Calvo-Garrido J, et al
    5-HT1B and other related serotonergic proteins are altered in APPswe mutation.
    Neurosci Lett. 2015;594:137-43.
    PubMed     Text format     Abstract available


    January 2015
  88. FINE JM, Renner DB, Forsberg AC, Cameron RA, et al
    Intranasal deferoxamine engages multiple pathways to decrease memory loss in the APP/PS1 model of amyloid accumulation.
    Neurosci Lett. 2015;584:362-7.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: